Skip to content

Application of dietary phosphorus management in dialysis patients with persistent hyperphosphatemia

Application of dietary phosphorus management in dialysis patients with persistent hyperphosphatemia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100051239
Enrollment
Unknown
Registered
2021-09-16
Start date
2021-06-01
Completion date
Unknown
Last updated
2022-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic renal insufficiency uremia

Interventions

control group:oral medicine and hemodialysis
Observation group:dietary phosphorus management and hemodialysis

Sponsors

The First Hospital of Jilin University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Uremia with chronic renal failure diagnosed by western medicine, aged 18-60 years; 2. Native Chinese, autologous arteriovenous fistula; 3. The average blood phosphorus level of the last three times and the last blood phosphorus level are >= 5.5mg/dl; 4. Long term use of lanthanum carbonate in the treatment of hyperphosphatemia; 5. Have normal reading, writing and communication skills; 6. Zhiqing agrees and participates voluntarily; 7. It can cooperate with 20 minutes of operation training.

Exclusion criteria

Exclusion criteria: 1. Severe dysarthria, hearing impairment, cognitive impairment and other reasons make the patient unable to cooperate with the scale evaluation; 2. Language impairment caused by disturbance of consciousness and general mental retardation; 3. Learning difficulties and language defects caused by congenital or childhood diseases; 4. Due to the functional impairment of important organs such as heart, liver and kidney, the researcher believes that it is not suitable to participate in this study; 5. Severe malnutrition, serum albumin < 25 g / L.

Design outcomes

Primary

MeasureTime frame
Blood phosphorus;blood calcium;parathyroid hormone;

Countries

China

Contacts

Public ContactZhou Li

Blood Purification Center of the First Hospital of Jilin University

zhou_l@mail.jlu.edu.cn+86 15804301299

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026